thyroid Flashcards
hyperthyroidism: list the causes of hyperthyroidism; recall the clinical features, explain the diagnosis, explain treatment options including mechanism of action, side effects, interactions and special circumstances (e.g. pregnancy); explain how to differentiate between Graves' disease and other causes of hyperthyroidism; recall the clinical features of a thyroid storm
4 classes of drugs used in treatment of hyperthyroidism
thionamides (thiourylenes; anti-thyoid drug), potassium iodide, radioiodine, B-blockers
2 examples of thionamides
propylthiouracil (PTU), carbimazole (CBZ)
what do thionamides (thiourylenes; anti-thyoid drug), potassium iodide and radioiodine classes attempt to do
reduce thyroid hormone symptoms
what does B-blocker class attempt to do
help with symptoms
3 clinical uses of thionamides
daily treatment of hyperthyroid conditions, treatment prior to surgery, reduction of symptoms while waiting for radioactive iodine to act
2 causes of hyperthyroidism
Graves’ disease, toxic thyroid nodule (Plummer’s disease)/toxic multinodular goitre
thyroid hormone synthesis
I- enters thyroid follicular cell from blood and passes into colloid via active transport -> coupling reaction occurs using peroxidase transaminase -> iodination of thryoglobulin occurs using thyroperoxidase and H2O2 -> T3 and T4 stored in colloid -> endocytosed and secreted
how do thionamides work to prevent T3 and T4 synthesis and secretion
inhibit thyroid peroxidase
thionamides: biochemical effect duration
hours
thionamides: clinical effect duration
weeks (colloid contains stored thyroxine)
thionamides: why might the treatment regimen include propranolol (B-blocker)
rapidly reduces tremor and tachycardia before clinical effect of thionamide
2 mechanisms of action of thionamides
may suppress antibody production in Graves’ disease, reduces conversion fo T4 to T3 in peripheral tissues (specifically propylthiouracil (PTU))
2 unwanted actions of thionamides
agranulocytosis (usually reduction in neutrophils; rare and reversible on withdrawal of drug), rashes (relatively common)
4 pharmacokinetic features of thionamides
orally active, carbimazole is pro-drug so must first be converted to methimazole, can cross placenta (pregnancy relevant) and are secreted in breastmilk (carbimazole (CBZ) more so than propylthiouracil (PTU)), metabolised in liver and excreted in urine
thionamides: follow up (duration and review)
usually aim to stop anti-thyroid drug treatment after 18 months, review patient periodically including thyroid function tests for remission (euthyroid) or relapse
anti-thyroid drug clinical effects
reduced tumour, slower heart rate, less anxiety
duration before anti-thyroid drugs have clinical effects
several weeks
what is used to achieve same clinical effects in interim before anti-thyoid drugs have clinical effect
non-selective (B1 and B2) B-blockers e.g. propranolol so all symptoms treated; less so with selective B1 blockers e.g. atenolol which only slow heart rate
when is iodide (usually KI, with doses x30 average daily requirement) used (2 conditions)
preparation of hyperthyroid patients for surgery, severe thyrotoxic crisis (thyroid storm) so quicker action required
2 KI mechanisms of action
inhibits iodination of thyroglobulin; inhibits H202 generation and thyroperoxidase (Wolff-Chaikoff effect)
what is the Wolff-Chaikoff effect
autoregulatory effect when thyroid hormone synthesis and secretion are both inhibited in presence of large doses of iodine
with KI, when do hyperthyroid symptoms reduce within
1-2 days